PGI Drug Discovery LLC (PsychoGenics), recently announced the achievement of a milestone in its drug discovery and development collaboration with Sunovion Pharmaceuticals Inc. In August 2007, PsychoGenics and Sunovion entered into a drug discovery and development agreement to combine their complementary strengths and expertise to identify a new generation of treatments for neuropsychiatric disorders